TABLE 3.
Predictors of treatment outcome based on interactions between time and the outcome measures.
| Predictor | BDI total score | CORE-OM total score | CORE-OM well-being | CORE-OM problems/symptoms | CORE-OM life functioning | CORE-OM risk/harm | ||||||||||||||||||||||||||||||
| df1 | df2 | F | p | R2 | Obs. pw | df1 | df2 | F | p | R2 | Obs. pw | df1 | df2 | F | p | R2 | Obs. pw | df1 | df2 | F | p | R2 | Obs. pw | df1 | df2 | F | p | R2 | Obs. pw | df1 | df2 | F | p | R2 | Obs. pw | |
| Sociodemographic variables | ||||||||||||||||||||||||||||||||||||
| Age | 3 | 48.19 | 0.13 | 0.944 | 0.19 | 0.08 | 3 | 45.66 | 0.22 | 0.884 | 0.15 | 0.10 | 3 | 45.75 | 1.01 | 0.395 | 0.22 | 0.21 | 3 | 45.66 | 0.02 | 0.995 | 0.13 | 0.02 | 3 | 47.40 | 1.42 | 0.250 | 0.13 | 0.36 | 3 | 49.42 | 0.91 | 0.442 | 0.09 | 0.35 |
| Gender | 3 | 48.29 | 1.04 | 0.383 | 0.20 | 0.00 | 3 | 45.75 | 1.17 | 0.331 | 0.16 | 0.00 | 3 | 45.57 | 1.21 | 0.318 | 0.21 | 0.00 | 3 | 46.02 | 1.15 | 0.340 | 0.14 | 0.00 | 3 | 47.23 | 1.37 | 0.264 | 0.14 | 0.00 | 3 | 49.47 | 1.64 | 0.191 | 0.10 | 0.00 |
| Clinical variables | ||||||||||||||||||||||||||||||||||||
| Psychotropic medication | 3 | 48.89 | 1.61 | 0.199 | 0.20 | 0.52 | 3 | 46.71 | 1.71 | 0.179 | 0.15 | 0.53 | 3 | 46.68 | 0.59 | 0.623 | 0.21 | 0.22 | 3 | 46.87 | 1.48 | 0.231 | 0.13 | 0.45 | 3 | 47.92 | 1.38 | 0.262 | 0.12 | 0.46 | 3 | 50.19 | 1.23 | 0.307 | 0.09 | 0.31 |
| Comorbidity | 3 | 48.00 | 1.38 | 0.259 | 0.20 | 0.00 | 3 | 45.89 | 0.65 | 0.588 | 0.15 | 0.00 | 3 | 45.47 | 0.91 | 0.443 | 0.22 | 0.00 | 3 | 46.06 | 0.87 | 0.462 | 0.13 | 0.00 | 3 | 47.30 | 0.49 | 0.691 | 0.13 | 0.00 | 3 | 48.65 | 0.26 | 0.856 | 0.11 | 0.00 |
| Type of symptoms (externalizing) | 3 | 48.85 | 0.18 | 0.907 | 0.19 | 0.00 | 3 | 46.31 | 0.03 | 0.993 | 0.16 | 0.00 | 3 | 45.93 | 0.09 | 0.965 | 0.22 | 0.00 | 3 | 46.47 | 0.29 | 0.836 | 0.14 | 0.00 | 3 | 47.95 | 0.41 | 0.747 | 0.13 | 0.00 | 3 | 50.07 | 0.14 | 0.933 | 0.08 | 0.00 |
| C-GAS baseline | 3 | 45.08 | 0.69 | 0.560 | 0.19 | 0.00 | 3 | 44.06 | 1.24 | 0.306 | 0.16 | 0.00 | 3 | 44.07 | 1.28 | 0.293 | 0.23 | 0.00 | 3 | 43.78 | 0.73 | 0.541 | 0.15 | 0.00 | 3 | 44.39 | 3.21 | 0.032 | 0.14 | 0.00 | 3 | 44.61 | 0.33 | 0.800 | 0.10 | 0.00 |
| BDI total score baseline | 2 | 45.03 | 0.79 | 0.459 | 0.71 | 0.00 | 2 | 43.67 | 0.23 | 0.795 | 0.52 | 0.00 | 2 | 44.49 | 0.54 | 0.589 | 0.46 | 0.00 | 2 | 43.55 | 0.15 | 0.860 | 0.47 | 0.00 | 2 | 44.24 | 0.14 | 0.867 | 0.45 | 0.00 | 2 | 44.20 | 1.49 | 0.237 | 0.40 | 0.00 |
| CORE-OM total score baseline | 2 | 45.07 | 0.78 | 0.463 | 0.62 | 0.00 | 2 | 43.75 | 0.24 | 0.786 | 0.58 | 0.00 | 2 | 44.80 | 0.75 | 0.479 | 0.52 | 0.00 | 2 | 43.71 | 0.16 | 0.855 | 0.55 | 0.00 | 2 | 44.04 | 0.06 | 0.941 | 0.52 | 0.00 | 2 | 43.82 | 1.52 | 0.230 | 0.39 | 0.00 |
| CORE-OM well-being baseline | 2 | 44.52 | 0.59 | 0.558 | 0.55 | 0.00 | 2 | 43.14 | 0.39 | 0.683 | 0.51 | 0.00 | 2 | 44.25 | 0.92 | 0.407 | 0.55 | 0.00 | 2 | 43.44 | 0.52 | 0.597 | 0.44 | 0.00 | 2 | 43.12 | 0.27 | 0.768 | 0.45 | 0.00 | 2 | 43.24 | 1.01 | 0.373 | 0.33 | 0.00 |
| CORE-OM problems/symptoms baseline | 2 | 45.14 | 0.77 | 0.468 | 0.56 | 0.00 | 2 | 43.97 | 0.18 | 0.834 | 0.58 | 0.00 | 2 | 44.80 | 0.66 | 0.521 | 0.49 | 0.00 | 2 | 43.76 | 0.08 | 0.922 | 0.61 | 0.00 | 2 | 44.47 | 0.12 | 0.884 | 0.46 | 0.00 | 2 | 43.62 | 1.33 | 0.274 | 0.34 | 0.00 |
| CORE-OM life functioning baseline | 2 | 44.94 | 1.15 | 0.326 | 0.48 | 0.00 | 2 | 43.70 | 0.50 | 0.610 | 0.45 | 0.00 | 2 | 44.49 | 1.05 | 0.358 | 0.42 | 0.00 | 2 | 43.83 | 0.21 | 0.815 | 0.36 | 0.00 | 2 | 44.22 | 0.38 | 0.685 | 0.49 | 0.00 | 2 | 43.94 | 1.11 | 0.338 | 0.26 | 0.00 |
| CORE-OM risk/harm baseline | 2 | 45.88 | 0.45 | 0.639 | 0.59 | 0.00 | 2 | 44.10 | 0.87 | 0.427 | 0.45 | 0.00 | 2 | 44.58 | 0.43 | 0.656 | 0.41 | 0.00 | 2 | 44.08 | 0.70 | 0.500 | 0.39 | 0.00 | 2 | 44.43 | 1.52 | 0.230 | 0.36 | 0.00 | 2 | 44.06 | 1.63 | 0.207 | 0.57 | 0.00 |
| Treatment-related variables | ||||||||||||||||||||||||||||||||||||
| Form of treatment | 3 | 48.58 | 0.14 | 0.935 | 0.19 | 0.04 | 3 | 45.99 | 0.17 | 0.917 | 0.16 | 0.05 | 3 | 45.69 | 0.42 | 0.741 | 0.21 | 0.12 | 3 | 46.14 | 0.53 | 0.661 | 0.14 | 0.12 | 3 | 47.32 | 0.45 | 0.721 | 0.13 | 0.15 | 3 | 48.99 | 0.30 | 0.826 | 0.09 | 0.10 |
| Frequency of treatment | 3 | 48.70 | 3.07 | 0.036* | 0.20 | 0.58 | 3 | 46.37 | 3.57 | 0.021* | 0.17 | 0.74 | 3 | 45.41 | 2.74 | 0.054* | 0.23 | 0.69 | 3 | 47.21 | 4.13 | 0.011* | 0.15 | 0.78 | 3 | 47.97 | 3.10 | 0.035* | 0.14 | 0.49 | 3 | 48.72 | 0.67 | 0.577 | 0.09 | 0.24 |
| Psychological variables | ||||||||||||||||||||||||||||||||||||
| Locus of control | 3 | 46.69 | 0.28 | 0.837 | 0.18 | 0.00 | 3 | 43.75 | 0.98 | 0.410 | 0.15 | 0.00 | 3 | 43.92 | 1.08 | 0.366 | 0.21 | 0.00 | 3 | 43.91 | 0.50 | 0.683 | 0.14 | 0.00 | 3 | 45.45 | 1.64 | 0.194 | 0.12 | 0.00 | 3 | 48.72 | 0.16 | 0.921 | 0.09 | 0.00 |
*Significant at p < 0.05 level.
C-GAS, Children’s Global Assessment Scale; BDI, Beck Depression Inventory; CORE-OM, Clinical Outcomes in Routine Evaluation – Outcome Measure; Obs.pw, Observed power.